Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis

BACKGROUND/PURPOSE: Clinical outcomes in pediatric ulcerative colitis (UC) in the era of biologic agents are poorly defined. We aimed to describe risk factors for colectomy in pediatric UC in the era of infliximab therapy. METHODS: We reviewed 217 pediatric patients at Texas Children’s Hospital with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pediatr Surg
Hlavní autoři: Ihekweazu, Faith D., Fofanova, Tatiana, Palacios, Ryan, Ajjarapu, Avanthi, Karam, Lina, Vogel, Adam M., Rodriguez, J R, Kellermayer, Richard
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396289/
https://ncbi.nlm.nih.gov/pubmed/32087936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2020.01.054
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky